Chimeric antigen receptor T (CAR-T) cell therapy is a promising and precise targeted
therapy for cancer that has demonstrated notable potential in clinical applications. However …

The clinical application of chimeric antigen receptor (CAR) T‐cell therapy has rapidly
changed the treatment options for terminally ill patients with defined blood‐borne cancer …

Targeted nanoparticles of different origins are considered as new-generation diagnostic and
therapeutic tools. However, there are no targeted drug formulations within the composition of …

Oncotheranostic nanoagents are powerful artificial tools that significantly outperform
traditional antitumor therapies. Among the wide variety of nanoagents, poly (lactic-co …

Therapy for aggressive metastatic breast cancer remains a great challenge for modern
biomedicine. Biocompatible polymer nanoparticles have been successfully used in clinic …

Nanoparticle-based chemotherapy is considered to be an effective approach to cancer
diagnostics and therapy in modern biomedicine. However, efficient tumor targeting remains …

Chimeric antigen receptor (CAR) T cell therapy for solid tumors shows promise, but several
hurdles remain. Strategies to overcome barriers such as CAR T therapy-related toxicities …

Background Modular (universal) CAR T-platforms were developed to combat the limitations
of traditional CAR-T therapy, allowing for multiple targeting of tumor-associated antigens …

Molecular targeted cancer therapy is a rapidly developing field, driving progress toward
greater treatment efficacy. However, targeted monotherapy often fails due to the …

Chimeric antigen receptor (CAR)‐T cell therapy is a transformative treatment against
advanced malignancies. Unfortunately, once administrated in vivo, CAR‐T cells become out …